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ABSTRACT 
Background: About one in 100 adolescents suffers from obsessive-compulsive disorder 
(OCD). OCD usually causes severe impairment in social, academic, and family functioning. 
As OCD often has a chronic course and is associated with a high risk for future psychological 
problems and disability, it is important to detect and treat the symptoms early in time. 
Cognitive behavior therapy (CBT) is recommended as the first choice treatment. 
Unfortunately, most sufferers do not have access to CBT, due to different factors such as 
limited health care resources and geographical distances. Internet-delivered CBT (ICBT) has 
been proposed as a solution to make effective treatments more available to patients. The 
feasibility and efficacy of ICBT are well studied for adults with OCD but have not been 
established for young people with OCD. 
Objective: The main objective of the studies included in this thesis was to develop and 
evaluate an ICBT intervention for adolescents with OCD. Specifically, we aimed to:  
1) test the feasibility and preliminary efficacy of ICBT for OCD in an open pilot study,  
2) test the efficacy of ICBT for OCD in a randomized controlled trial,  
3) study the cost-effectiveness of ICBT for OCD, and  
4) evaluate predictors of treatment response to ICBT for OCD from baseline patient 
characteristics.  
Methods: We developed a novel ICBT intervention for adolescents with OCD and their 
parents – named “BiP OCD” – and conducted an open pilot study with 21 adolescents with 
OCD (study I). In the second study, we randomized 67 adolescents with OCD to either ICBT 
or a waitlist of equal duration (study II). To evaluate the cost-effectiveness of ICBT, we 
collected cost data on health care utilization, medication use, school absence, and 
productivity loss in the same sample alongside the randomized controlled trial (study III). All 
patients that had received ICBT in the randomized controlled trial, either immediately or after 
the waitlist, were then pooled together (N=61) and analyzed regarding baseline predictors of 
treatment response three months after ICBT (study IV). Predictor analyses were conducted 
with classical linear regression as well as with machine learning methodology.  
Results: Large within-group effects of ICBT were observed in studies I and II. Between-
group comparison with the waitlist group in study II revealed moderately sized treatment 
effects. Overall, patients were highly satisfied with the intervention. The average clinician 
time was below 20 minutes per patient and week. Study III identified cost-saving effects of 
ICBT when compared with untreated patients on the waitlist, indicating that it is more costly 
for society to not treat those patients than to offer ICBT. In study IV, linear regression 
analyses could not identify any predictors for ICBT treatment response. However, machine 
learning algorithms predicted treatment response with high accuracy.  
Conclusions:  The results presented in this thesis provide support for the feasibility, efficacy, 
and cost-effectiveness of ICBT for adolescent OCD. Machine learning methodology is a 
novel, promising statistical approach that could guide us to more accurate predictions of 
treatment outcome. The results warrant replication in larger clinical samples and in 
comparison with active control conditions as well as face-to-face CBT.  
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1 INTRODUCTION 
Having a background as a clinical psychologist, I have experienced the problems that mental 
health services struggle with on a day-to-day basis. The high demand for child and adolescent 
mental health care at our local unit, with many families that were seeking help, had to 
somehow be balanced with the limited time in the schedules of the available clinicians. 
Regularly this led to tough decisions about which families could get earlier appointments and 
which patients had to wait a bit longer. Over the years, this situation got more and more 
challenging, with more children and adolescents seeking specialized treatment for their 
difficulties in a problematic combination with limited resources available at the clinic. It 
appears that the increasing demand for mental health care is not just affecting the health care 
services in Stockholm, but is an international trend that burdens many countries’ health care 
systems.  
Since I have come in contact with e-health and Internet-delivered treatments I firmly believe 
that one solution to the dilemmas of modern mental health care will come from innovation 
and development of new technologies. Gladly, the results in the field of Internet-delivered 
cognitive behavior therapy (ICBT), including the results presented in this thesis, are 
promising. The available research indicates that these innovative treatments work, and also 
that they could save precious time, resources, and costs for health care providers and society. 
Nevertheless, ICBT is not yet available for children and adolescents.  
The prerequisites leading up to the current PhD project were a combination of my own 
personal and professional frustration over an over-burdened child and adolescent mental 
health care system, an unusual high concentration of ICBT and obsessive-compulsive 
disorder (OCD) experts in the Stockholm area, and a critical mass of academic and clinical 
decision makers that were willing to open up a window of opportunity for the development of 
this new Internet-delivered treatment for pediatric OCD.  
Thanks to this fortunate combination of factors, I have been able to study some of the most 
relevant questions that one might ask about ICBT for adolescents with OCD, namely “Does it 
work?”, “Who does it work for?,” and “Could this be a way to use our limited health care 
resources more efficiently?”. The results presented in this thesis are of course limited by 
design and method, but provide us with preliminary answers to these important questions and 
also indicate how to continue the scientific evaluation of this novel intervention.  
Importantly, there are currently several initiatives, from ongoing international research in the 
field of ICBT for children and adolescents to the nationwide implementation of an e-health 
platform in Sweden, which will further increase the probability that the results presented in 
this thesis will actually be of use in clinical settings and will contribute to increase the 
availability of effective care for children and adolescents with mental health problems.  
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2 BACKGROUND 
2.1 CHARACTERISTICS OF PEDIATRIC OBSESSIVE-COMPULSIVE 
DISORDER  
 Diagnostic features, prevalence, and course of pediatric OCD  2.1.1
Obsessive-compulsive disorder (OCD) is characterized by recurrent, anxiety provoking 
thoughts or images (obsessions) and compulsive behaviors or rituals (compulsions), often 
aimed to prevent a dreaded event or feeling of distress 
1
. Typical examples of obsessions are 
fearful thoughts of being contaminated, catching a disease, or causing harm to others. Typical 
compulsions are ritualistic checking and excessive washing behaviors. OCD affects one to 
two out of 100 children 
2,3
, and similar prevalence rates are also found in the adult population 
4,5
. Symptom onset occurs most often before the age of 25 and about 30 to 80% of patients are 
affected in childhood or adolescence 
6,7
. Interestingly, there appear to be two peaks of onset, 
one in childhood, about the age of 11, and one in early adulthood, around the age of 23 
8
.  
As prevalence rates from childhood to adulthood do not increase very much, some have 
speculated that the natural course of OCD is not chronic for all youth, as we otherwise should 
see accumulating prevalence rates across the lifespan 
9
. Indeed, long-term follow-up studies 
show that only some OCD patients experience a chronic course: 40 to 60% have persisting 
symptoms in the long-term 
9,10
. It should be noted that these rates were observed in treated 
patients, and little is known about the natural course of OCD in untreated individuals. Studies 
from the adult field indicate that at least 50% of cases face a chronic course if left untreated 
11,12
.  
The presence of comorbid psychiatric diagnoses is the rule rather than the exception, and 
more than half of children and adolescents with OCD have also other mental health 
conditions 
13
. Increased rates of major depression, anxiety disorders, tic disorders, disruptive 
behavior, attention-deficit/hyperactivity disorder (ADHD), and mania have been reported 
13
. 
Moreover, OCD in childhood increases the risk of mental health problems in adulthood 
14
 and 
is as well associated with higher risk of suicide, compared to individuals without OCD 
15
.  
 Impairment and societal impact of OCD  2.1.2
Pediatric OCD is commonly associated with severe impairments in academic, social, and 
family functioning, with 90% of children and adolescents experiencing OCD-related 
dysfunction in everyday life 
16
. OCD often has negative effects on family life and the parents’ 
everyday functioning, with about half of mothers and one-third of fathers reporting daily 
occupational impairment due to the child’s symptoms 17. In adulthood, individuals with OCD 
are more likely to be unemployed, have lower socioeconomic status and income, are less 
likely to be married and report in general poorer social and occupational functioning than 
non-affected controls and individuals with anxiety or mood disorders 
18
.  
On a societal level, OCD has been found to generate large direct costs due to health care 
utilization, but even larger indirect costs due to loss of income, sick leave, and unemployment 
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19
. In a study from the U.S., the total cost of OCD was estimated to be $8.4 billion in 1990, 
5.7% of the costs of all mental illness, and 18% of the costs of all anxiety disorders 
20
. Data 
from Medicaid-insured patients in the U.S. suggest that the health care costs of OCD are 
comparable to those found in depression 
21
. These numbers indicate that OCD is associated 
with a significant burden for health care and national budgets, even though more updated cost 
estimates are needed as well as estimates for European and Scandinavian settings.  
 Etiology and maintenance of pediatric OCD  2.1.3
Despite extensive research efforts, the exact causes of OCD are relatively unclear. The 
etiology of OCD is currently understood as a multifaceted interplay between environmental, 
genetic, and neurofunctional factors (see Figure 1). About half of the variance of OCD 
symptoms is under genetic influence, half under influence of unique environmental factors 
22,23
. OCD has a tendency to cluster in families, primarily due to the genetic heritability of the 
condition, with first-degree relatives having a 5-fold risk of developing OCD 
23,24
. Genetic 
studies indicate a multifactorial interplay between the serotonergic, dopaminergic, and 
glutamatergic neurotransmitter systems 
24
.  
Environmental risk factors are still poorly understood but are likely to play a role. There is 
some evidence that perinatal complications 
25
, stressful life events, and factors related to the 
reproductive cycle could affect the risk for OCD 
26
. Moreover, environmental factors may 
also play a role in epigenetic mechanisms that turn relevant genes on or off 
24
. 
Some consensus exists about the conceptualization of OCD as a neuropsychological 
condition, with a neurofunctional circuit that involves cortical, striatal, and thalamic regions –
also known as the cortico–striato–thalamo–cortical model of OCD 24.  
 
 
Figure 1: An integrative model of genetics, environment, and neurobiology for the expression of 
OCD  
(reprint from Pauls DL, Abramovitch A, Rauch SL, et al. Obsessive-compulsive disorder: an integrative genetic and neurobiological 
perspective. Nat Rev Neurosci 2014;15:410–24. doi:10.1038/nrn3746 with permission from the Nature Publishing Group) 
 
Psychological models have aimed to explain the self-maintaining nature of OCD, and have 
later on contributed to the development of effective psychological treatments. Initially, 
psychological theories of learning had difficulties in defining the mechanisms of anxiety and 
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OCD symptoms. The classical pavlovian (learning of behavior through the association of two 
stimuli) and skinnerian (learning of behavior as a consequence of reinforcement) models 
predict that a behavior would vanish if not further maintained by association or reinforcement 
– when, in fact, a typical OCD ritual is maintained and frequently repeated without additional 
pairing with the original stimulus or any further reinforcement in the skinnerian sense.   
The two stage theory of Mowrer 
27
 expanded the previous learning theories in order to 
explain fear acquisition and maintenance more accurately (see Figure 2). The theory 
proposed, and demonstrated in animal models, that fear (distress/anxiety) can be acquired in a 
first step just as Pavlov would have expected it: a previously neutral stimulus (conditioned 
stimulus, CS = a bell) can acquire fearful properties when associated repeatedly with a fear-
eliciting stimulus (unconditioned stimulus, USC = electric shock). In the second step of his 
theory, Mowrer demonstrated that a learned avoidance behavior (such as a ritual) reduces the 
distressing emotion and therefore the avoidance behavior is reinforced through the 
mechanism that we call negative reinforcement. The distress reducing nature of compulsions 
was later confirmed in a series of lab experiments in humans with OCD 
28,29
. In other words, 
rituals and compulsive behaviors are maintained as they indeed reduce anxiety and distress in 
the short term.  
 
   
Figure 2: Mowrer’s two factor theory 
(Abbreviations: UCS = unconditioned stimulus; CS = conditioned stimulus; UCR = unconditioned response; CR = conditioned response) 
 
In the 1980’s, the behavioristic understanding of OCD was further expanded with a cognitive 
perspective, underlining that individuals with OCD show typical, erroneous cognitions about 
the harmfulness of negative outcomes, as well as exaggerated feelings of responsibility for 
one's thoughts and actions in order to prevent oneself or others from harm 
30,31
. It has been 
demonstrated that unwanted intrusive thoughts or images, as typically found in OCD, are 
very common in the general population 
32
. This emphasizes the notion that intrusive thoughts 
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are a common phenomenon, and unproblematic for most of us. It is therefore not the 
occurrence of intrusive thoughts per se, but rather the appraisal of those thoughts as 
important, unacceptable, immoral, or threatening that creates problematic consequences and 
symptoms 
33
.  
The current psychological model of OCD integrates cognitive and behavioral mechanisms 
and can be described as a self-maintaining sequence of events (see Figure 3): Normal 
cognitive content (e.g. “Have I turned off the stove?”) is misinterpreted as threatening (“The 
house will burn down!”), amplified by maladaptive core beliefs (“I have 100% responsibility 
to always protect others from harm.”). This triggers anxiety and the urge to counteract the 
obsessive cognitions and feared consequences of one's actions. In the short term, anxiety is 
reduced by rituals (e.g. repeatedly checking the stove), but in the long term, the cognitive and 
behavioral drivers of obsessions and compulsions are maintained in a circular manner 
33
.  
 
 
Figure 3: Cognitive behavioral model of OCD  
(reprint of Abramowitz JS, Taylor S, McKay D. Obsessive-compulsive disorder. Lancet 2009;374:491–9. doi:10.1016/S0140-
6736(09)60240-3 with permission from Elsevier) 
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2.2 EVIDENCE-BASED TREATMENTS FOR PEDIATRIC OCD  
 Cognitive behavior therapy 2.2.1
In the past, OCD was considered an untreatable condition. As late as in the early 1980’s, it 
was stated that “OCD is notoriously difficult to treat. The abundance of therapeutic 
approaches available indicates that none is clearly effective in the majority of cases” (Jenike, 
1983, p. 105) 
34
. However, the first report of successful OCD treatment can be dated back to 
1966. In a case study by Mayer, a new therapeutic approach involving “modification of 
expectations” and “reality testing” was presented 35. Even if it should take more than two 
decades to make Mayer’s method known to a broader audience, the method described in his 
early report became later the gold standard of psychological treatment for OCD and is today 
known under the term exposure and response prevention (ERP).  
In short, ERP consists of 1) exposure to the obsession-eliciting stimulus (e.g. touching a 
doorknob, and by that triggering intrusive thoughts about germs) combined with 2) the 
prevention of compulsions or rituals (e.g. not washing the hands despite intrusive thoughts 
about disease and strong discomfort). ERP is typically done in a gradual, systematic manner 
over the course of 12 to 14 weeks, and is the main ingredient of the recommended cognitive 
behavior therapy (CBT) regimen according to clinical expert guidelines 
36–38
. Apart from 
ERP, CBT protocols usually also include psychoeducation, cognitive strategies, and relapse 
prevention 
39
. Little is known about the specific effect of each of those treatment components, 
though there is a broad consensus that ERP is a necessary ingredient in good-quality CBT for 
OCD 
40,41
.   
Some controversy exists about what underlying mechanisms in ERP cause the decrease in 
symptoms that we observe as a result of ERP-based CBT. The most prominent and accepted 
theory is Foa and Kozak’s emotional processing theory 42. It poses that ERP yields a 
“corrective learning” process through the initial activation of fear through the feared stimulus 
and gradual habituation in prolonged presence of the stimulus. Through repetitive exposure to 
the feared stimulus, as well as subsequent habituation, new, non-fear based information is 
integrated and replaces the previous fear-based associations. However, it should be 
mentioned that there have been some criticisms of the emotional processing theory lately and 
inhibitory learning approaches have been suggested instead. The inhibitory learning model 
states that fear associations, once learned, do not vanish as a result of exposure, but rather 
coexist with the new non-fear associations 
43
. The model implies a different set of therapeutic 
strategies, such as creating a maximal discrepancy between and the patient’s expectations and 
the outcome of an ERP exercise, and not necessarily increasing the difficulty of ERP 
exercises gradually but instead focusing on variability between ERP tasks, which perhaps has 
beneficial effects for the long-term treatment outcomes 
44
. 
Overall, there is a broad evidence base for the treatment of OCD with CBT, with currently 37 
randomized controlled trials (RCTs) in the adult field 
45
 and 25 in the child and adolescent 
field 
46
. CBT is effective for the majority of children and adolescents with OCD, with about 
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70% responding to treatment (for comparison, only 9% respond to non-active comparison 
conditions and 23% to other non-CBT active comparison conditions) 
47
.  
 Prediction of CBT treatment outcome in pediatric OCD 2.2.2
Regarding recommendations of which children and adolescents with OCD should be offered 
CBT, there have been numerous attempts to find reliable predictors of treatment outcome. 
Prediction studies aim to identify patient characteristics that either increase or decrease the 
probability of a treatment to be effective, which is important knowledge in order to not offer 
patients treatment alternatives that are likely to be ineffective. For example, a hypothesis 
could be that patients with more severe OCD symptoms and several comorbid diagnoses 
would benefit less from CBT than patients with mild symptoms and no comorbidity.  
A summary of previous pediatric OCD prediction studies of CBT outcome from 1995 to 
2014 
10,37,48–59
 shows that a wide variety of potential predictors of CBT outcome has been 
studied (see Table 1). 
Table 1: Summary of significant and non-significant results of previous prediction studies 
  Frequency 
of 
significant 
results 
Frequency 
of non-
significant 
results 
Demographic variables Sex * xxxxxx 
 Age * xxxxxx 
 Household income/SES  xx 
OCD related variables OCD severity **** xxxx 
 OCD functional impairment *** xx 
 Social adjustment  x 
 Onset of OCD  xxx 
 Duration of OCD ** xx 
 Insight *  
 OCD dimensions  x 
Comorbidity Externalizing comorbidity  * xxx 
 Comorbid anxiety  xxxxxx 
 Comorbid depression  xxxxx 
 Comorbid tics * xxx 
Family variables Family accommodation ** x 
 Family dysfunction  ** x 
 Family history of OCD  xxx 
 Parental psychopathology  xxx 
Other Medication  xxx 
 Therapist experience  x 
 Therapy adherence * x 
Note: SES = socioeconomic status;  
* = variable has been studied and found a significant predictor of CBT treatment outcome;  
x = variable has been studied and was not found a significant predictor of CBT treatment outcome 
 
As can be seen in Table 1, the results within the prediction field are largely inconclusive and, 
currently, there are no reliable clinical or demographic variables that consistently predict 
outcome across different studies 
60
. There could be methodological reasons for this, such as 
suboptimal predictor selection and measurement, choice and power of the chosen statistical 
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method, and choice and operationalization of outcome variables 
60,61
. To overcome those 
methodological limitations, it has been suggested to introduce novel machine learning 
methods when studying predictors 
62
. Machine learning is a family of statistical methods with 
the potential to model complex linear and non-linear data. Machine learning has, for example, 
been widely explored within the field of cancer prognosis, with over 1.000 published articles 
on the topic 
63
. Currently, machine learning has only been very sparsely applied to the 
prediction of OCD treatment outcome, with the exception of one study in which remission 
could be successfully predicted with an accuracy of 75% in a large sample of adults with 
OCD 
64
. Clearly, there is a need for the development of reliable methods to inform clinicians 
and researchers about which patients have the best chances to benefit from CBT.  
 Pharmacological treatment  2.2.3
Serotonin reuptake inhibitors (SRIs) are recommended as a secondary treatment alternative 
for pediatric OCD, either as monotherapy or in conjunction with CBT as a combined 
treatment 
36–38
. SRIs are effective for a substantial proportion of patients, with 50% treatment 
responders (versus 25% treatment responders in placebo conditions) 
47
.  
A common recommendation is that severe cases of OCD should receive combination 
treatment of CBT and SRIs 
37
. However, that recommendation appears to be based on one 
single trial 
65
, and it has in fact not been demonstrated in the results of the study that 
combination treatment is superior in severe OCD cases. Recent meta-analyses have 
concluded that there is no empirical evidence that the combination of CBT and SRIs would 
be more effective than CBT monotherapy 
46,66
. SRIs are however an important treatment 
alternative when CBT is not available, or as part of a clinical strategy in personalized 
multimodal treatment.  
2.3 THE DILEMMA OF ACCESSIBILITY  
Considering that about 20% of children and adolescents suffer from a mental disorder 
67
 and 
that half of all adult mental disorders have an onset before the age of 15 
68
, the early detection 
and treatment of childhood psychological disorders is an important public health question. 
Evidence-based psychological interventions for the treatment of pediatric mental disorders 
exist. However, many sufferers do not receive those treatments, presumably as a consequence 
of limited therapeutic resources and access to them 
67,69
.  
In the case of OCD, there are large geographic inequalities regarding the availability of 
proper assessment and treatment 
69,70
, and a majority of cases are not detected by the health 
care system 
71
. In addition, diagnosed OCD cases are seldom treated with effective 
psychological interventions 
72. As a result, many patients’ suffering is prolonged. For 
instance, one study in adults with OCD found that the delay from OCD symptom onset (12 
years of age) to receiving effective treatment was on average 17 years 
73
. A study in children 
indicated that the delay from OCD onset to receiving treatment was about 3.5 years 
10
.  
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Little is known about the treatment barriers that keep children and adolescents with OCD 
from receiving effective treatment. Studies from the adult field have identified several 
treatment barriers, including treatment costs 
74
, lack of insurance coverage 
74
, doubt about 
treatment being beneficial 
74,75
, belonging to an ethnic minority 
75,76
, as well as shame and 
stigma 
74,77
. An obvious but understudied barrier is whether families live geographically close 
to those mental health services that provide adequate treatment 
78
.  
Moreover, the implementation of evidence-based practices within health care has been 
lagging behind due to organizational challenges 
79
. Studies indicate that when implemented in 
regular health care, CBT often is delivered with suboptimal quality 
80
. In fact, one study 
showed that, of the clinicians that offer CBT for pediatric OCD, only one third would provide 
effective ERP-based treatment 
72
. Another study found that 95.5% of youth with OCD had 
received inadequate CBT in primary psychiatric care prior to referral to a specialized clinic 
81
.  
2.4 INTERNET-DELIVERED COGNITIVE BEHAVIOR THERAPY  
Given the challenges of implementation of evidence-based care and the low accessibility of 
good quality CBT, the development of e-health and Internet-delivered mental health 
interventions has been proposed 
82
. Internet-delivered Cognitive Behavior Therapy (ICBT) 
has emerged as a cross-disciplinary development of psychological intervention research and 
modern information technology. The content and treatment components of ICBT are not 
different from regular CBT, the only difference being that ICBT is presented to the patient 
via the Internet 
83
. The ICBT format is very similar to that of an Internet e-learning course, 
with educative texts, visual material such as images and videos, exercises to work with and, if 
therapist support is included, e-mail functionality.  
Internet-delivered interventions have the potential to make evidence-based treatments more 
accessible to patients, as those interventions are less bound to temporal and geographical 
barriers. The main additional advantage of ICBT over other innovative formats such as 
treatments given via the telephone 
84
 or web-camera 
85
 is that therapist times can be markedly 
reduced to on average 10 to 20 minutes per patient/week 
86
. Some studies have tested a self-
guided ICBT model without therapist support, which of course, even more, minimizes the 
resources required from health care. However, meta-analytic results from the adult OCD field 
indicate that interventions with therapist contact yield larger effect sizes and lower dropout 
rates than pure self-guided interventions 
87
. Yet, there is little available evidence regarding 
this question from the child and adolescent ICBT field 
88
.  
Overall, there is a substantial body of evidence for ICBT in adult patient populations with 
several systematic reviews and over 100 RCTs indicating effectiveness for various 
psychiatric conditions 
89–91
. Studies have consistently demonstrated positive results of 
Internet-based treatments’ efficacy compared to non-active controls, but have also been able 
to show results comparable to standard face-to-face CBT 
92
. In addition, there have been rare 
but highly successful examples of implementation of ICBT in regular mental health care for 
adults in Sweden, Australia, and the Netherlands 
93–95
.  
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In the OCD field there have been several ICBT studies on adult patients that have repeatedly 
shown effects comparable to face-to-face CBT with large effect sizes and about 50 to 60% 
treatment responders 
86,96–99
, and sustained long-term effects up to two years after treatment 
100
. Previous to the trials presented in this thesis, no study had demonstrated the efficacy of 
ICBT for children or adolescents with OCD.   
 ICBT for children and adolescents  2.4.1
Despite the fact that children and adolescents are the most active age group on the Internet, 
with a usage of over 90% 
101
, research on ICBT for pediatric patient populations has been 
significantly lagging behind.  
A comprehensive systematic review and meta-analysis from 2016 included both randomized 
and non-randomized ICBT studies from the child and adolescent field and identified twenty-
five studies 
88
. About half of the studies concerned somatic conditions, targeting, for example, 
overweight and pain disorders. The other half of the studies corresponded to the psychiatric 
field, with anxiety disorders being the most frequently studied diagnostic area.  
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Figure 4: Between-group effect sizes of ICBT in children and adolescents compared to waitlist, active 
control and face-to-face CBT  
(reprint from Vigerland S, Lenhard F, Bonnert M, Lalouni, M et al. Internet-delivered cognitive behavior therapy for children and 
adolescents: A systematic review and meta-analysis. Clin Psychol Rev 2016;50:1–10. doi:10.1016/j.cpr.2016.09.005, creative commons 
license) 
 
Figure 4 presents the between-group effect sizes from the meta-analysis, comparing ICBT to 
waitlist, active control conditions, or face-to-face CBT. The effect size for ICBT when 
compared to waitlist was moderate. The comparisons with active control conditions and face-
to-face CBT were few, with only three studies each, and conclusions from those comparisons 
were therefore rather limited. Several methodological weaknesses were found in the field, 
e.g. several trials with unblinded assessors, not reporting intent-to-treat analyses and no 
monitoring of adverse events. The authors highlighted the need for more rigorously 
conducted studies and warranted more systematic reporting of core features of ICBT such as 
therapist times, cost-effectiveness, and geographic reach 
88
.  
To conclude, ICBT appears to be a promising intervention for children and adolescents with 
various mental health conditions, but it is currently unclear whether ICBT could be effective 
for pediatric OCD.  
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 Cost-effectiveness of ICBT  2.4.2
A health care intervention is considered cost-effective if it yields better outcomes than 
another intervention in relation to the costs that each intervention is associated with 
102
. In 
other words, if a new intervention A yields better outcomes than the standard intervention B, 
and intervention A is cheaper than B, then A is more cost-effective. In situations where a new 
intervention is more expensive but also more effective than the standard intervention, an 
evaluation has to be made to decide whether the additional benefits of the new intervention 
are worth the additional costs. This is determined by the health care system’s “willingness to 
pay” for the additional effect of the more expensive intervention 102. Costs can be estimated 
on different levels (e.g. costs for the individual, costs for the health care sector, or costs for 
society as a whole).  
In ICBT, it would be reasonable to assume that cost savings can be made, given the Internet-
delivered format which does not require the patients and parents to travel to the clinic and 
does not interfere with school or working times in the same way than regular CBT. Also, 
therapist times are usually reduced, compared to face-to-face interventions, indicating cost 
savings for the health care system 
89
.  
A systematic review of ICBT for adult patient populations concludes that ICBT probably is a 
cost-effective intervention when compared to no treatment control conditions 
89
. In addition, 
a study in adult social anxiety disorder demonstrated that ICBT was equally effective but 
more cost-saving than face-to-face CBT 
103
. To the best of my knowledge, there are currently 
no published studies that have presented data on the cost-effectiveness of ICBT in the 
pediatric anxiety or OCD and related disorders field.  
Importantly, it should be mentioned that there is very little knowledge about the cost-
effectiveness of gold standard face-to-face CBT or pharmacological treatments for pediatric 
OCD. A comprehensive systematic review done by the UK National Institute of Health 
Research in 2016 did not find any empirical cost-effectiveness data on standard face-to-face 
CBT or SRI treatment for pediatric OCD 
104
. This highlights the need to not only evaluate 
novel interventions, but also the established gold standard treatments from a health economic 
perspective. 
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3 RESEARCH QUESTIONS 
 
The objective of this Ph.D. project was to develop and evaluate a novel ICBT treatment for 
adolescents with OCD. The project aimed to answer the following questions:  
1. Is ICBT a feasible and effective treatment for adolescents with OCD? 
2. Is ICBT for pediatric OCD associated with health-economic benefits for society and 
health care providers? 
3. Which OCD patients does this treatment work for? 
In order to answer these questions, the project was divided into four different studies:  
Study I: Development and test of the feasibility of ICBT for pediatric OCD in a pilot study  
Study II: Evaluation of the effectiveness of ICBT in a randomized controlled trial  
Study III: Analysis of cost-effectiveness of ICBT compared to untreated patients (same 
study sample as study II) 
Study IV: Analysis of predictors of treatment outcome (same sample as study II) 
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4 THE EMPIRICAL STUDIES 
4.1 THE ICBT INTERVENTION 
The ICBT platform, called BiP platform (Barninternetprojektet), was initially built in 2010 
and specially tailored to accommodate the needs and graphical preferences of children and 
adolescents. Since then, the BiP platform has been used in several ICBT projects for children 
with anxiety 
105,106
 and adolescents with irritable bowel syndrome 
107,108
, and is currently 
being used in ongoing trials for children and adolescents with OCD, tics/Tourette’s 
syndrome, social anxiety disorder, excessive worry, functional gastrointestinal disorders, and 
self-harm. The platform has continuously been optimized regarding graphical appearance and 
functionality and can be used for the presentation of written text, video and audio material, 
images, forms to fill in, and functionality for communication with clinicians through e-mails 
and comments.  
The ICBT content of the OCD intervention, “BiP OCD”, was developed in 2012. BiP OCD is 
completely web-based and involves both the adolescent as well as the parents. The 12-week 
intervention consists of 12 chapters that contain texts to read and films and illustrations to 
watch, as well as different kinds of exercises for the adolescents to do on their own and 
together with the parent. The content of BiP OCD is in line with expert recommendations of 
CBT for pediatric OCD 
37,109
. It is divided into three treatment phases (see Table 2), starting 
with psychoeducation regarding OCD and the rationale for cognitive behavioral 
interventions. The second phase is the main part of the treatment and contains behavioral 
interventions, mainly ERP, as well as cognitive restructuring. Phase three addresses problem 
solving, maintenance of treatment gains, and relapse prevention. Through a separate login, 
parents get access to material that focuses on parent-specific content, such as family 
accommodation, parental coping strategies, and how to support the adolescent to adhere to 
the treatment and practice ERP. During the treatment period, participants have regular contact 
with the therapist through e-mails, standardized forms, and occasional phone calls.  
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Table 2: An overview of the content of BiP OCD 
Treatment phase Chapter Parent chapters Adolescent chapters 
Psychoeducation 1 Introduction to ICBT Introduction to ICBT 
 2 About OCD What is OCD? 
 3  We are cracking the code: The OCD circle 
 4 Exposure and response prevention Building a hierarchy 
Exposure and  5  Testing exposure 
response 6 Being an exposure coach Planning your ERP training 
prevention  7  New steps with ERP 
(ERP) 8 When the family has OCD ERP – frequent problems and solutions 
 9  More new steps with ERP 
 10  Talking back to OCD - Coping with obsessions 
Relapse  11  The final sprint 
prevention 12  Your treatment in the rear-view mirror 
 
BiP OCD was initially tested in an open pilot trial, study I 
110
, and has been further developed 
between study I and study II 
111
. Besides a general update of the material, a smartphone 
application was added to support the intervention. The smartphone app was designed with 
functionality to plan and register ERP exercises. Figure 5 displays screenshots from BiP 
OCD.  
 
 
Figure 5: Screenshots from BiP OCD  
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4.2 STUDY I: FEASIBILITY OF ICBT FOR ADOLESCENTS WITH OCD 
Aim 
The primary aim was to test the feasibility and within-group efficacy of the ICBT 
intervention. The study was also a way to collect information about how to further improve 
the intervention, as well as to guide proper sample size calculations for the subsequent RCT.  
Methods 
We conducted an open trial with twenty-one adolescents with OCD aged 12 to 17. All 
patients received ICBT. The primary outcome was the clinician-rated Children’s Yale-Brown 
Obsessive Compulsive Scale (CY-BOCS) 
112
 administered before, after, and three and six 
months after treatment. Secondary outcomes were self- and parent-rated measures of OCD, 
comorbid symptoms, and impairment.  
Main results 
ICBT yielded significant symptom severity reductions on the CY-BOCS with large within-
group effect sizes from pre- to post-treatment (d=2.29 [95% CI 1.5–3.07]) and 57% treatment 
responders. Additional symptom reductions were observed at the 3-month follow-up, where 
71% of patients reached responder status. Significant reductions were also found on patient- 
and parent-rated measures of OCD severity and impairment, as well as on measures of 
comorbid anxiety, depression, and family accommodation. The average therapist time spent 
per patient and week was 19.5 minutes. The ICBT intervention received good to very good 
satisfaction ratings from the patients.  
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4.3 STUDY II: EFFICACY OF ICBT FOR ADOLESCENTS WITH OCD 
Aim 
This study aimed to test the efficacy of ICBT for adolescent OCD in a randomized controlled 
study design. In addition, adverse events, clinician times, and geographic reach were 
measured.  
Methods 
Sixty-seven adolescents with OCD aged 12 to 17 years were randomly assigned to either 
ICBT or a waitlist for a period of 12 weeks each. Patients on the waitlist crossed over to 
ICBT after the initial 12 weeks. Measures were taken at pre-, post-, and three months after 
treatment. The primary outcome measure was the clinician-rated CY-BOCS 
112
, administered 
by blinded raters. Secondary outcomes were self- and parent-rated measures of OCD, 
comorbid symptoms, and impairment. 
Main results 
ICBT was superior over the waitlist in reducing OCD symptom severity with a moderate 
between-group effect size (d=0.69 [95% CI 0.19–1.18]) and 27% treatment responders, 
compared to 0% in the waitlist. Patients continued to improve on the CY-BOCS from post-
treatment to the 3-month follow-up, with 32% responders at that time point. Patients on the 
waitlist that crossed over to ICBT demonstrated a similar reduction of symptoms after 
treatment and at 3-month follow-up. There were no severe adverse events. The average 
therapist time per patient and week was 17.5 minutes. Most patients in the sample lived 
within a 20 km range from the clinic; however, some patients lived more than 400 km away.  
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4.4 STUDY III: COST-EFFECTIVENESS OF THE ICBT INTERVENTION 
Aim 
The aim of the study was to explore the cost-effectiveness of ICBT in pediatric OCD patients 
compared to untreated patients on a waitlist. 
Methods 
Sixty-seven adolescents with OCD aged 12 to 17 years participated in a single-blind RCT 
comparing ICBT to a waitlist control for a period of 12 weeks (study II). Clinical 
effectiveness outcomes were defined as treatment responder rates and change in Quality 
Adjusted Life Years (QALYs) from pre- to post-treatment. Cost data on health care use, 
informal resource use, prescription drugs, prescription-free drugs, school absence, and 
productivity loss, as well as the cost of ICBT was collected.  
Main results 
There was a significant difference in the percentage of treatment responders in ICBT 
compared to the waitlist group (27% versus 0%, respectively). No effect on QALYs was 
observed. Compared to the waitlist group, ICBT generated substantial cost savings, averaging   
-144.98USD (95% CI [-159.79, -130.16]) per patient. The cost savings were mainly driven by 
reduced health care use in the ICBT group relative to the waitlist. From a health care provider 
perspective (i.e. considering general health care costs, medicine costs, and the cost of ICBT), 
the additional cost of ICBT was about 20US$ per patient or 2.3US$ per additional responder.  
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4.5 STUDY IV: PREDICTION OF ICBT TREATMENT OUTCOME 
Aim  
As the literature on prediction of treatment outcomes in OCD is inconclusive, possibly due to 
suboptimal statistical methods, we aimed to test a novel machine learning approach for the 
prediction of ICBT outcome for pediatric OCD.  
Methods 
All sixty-one adolescents with OCD that had received 12 weeks of ICBT in a previous RCT 
(study II) were analyzed. Available demographic and clinical baseline variables were used to 
predict treatment outcome. Outcome (treatment response) was assessed three months after 
ICBT. Four machine learning algorithms were implemented (one linear and three flexible 
models), as well as, for comparison, a classical logistic regression analysis.  
Main results 
Multivariate logistic regression could not detect any significant predictors. In contrast, all 
four machine learning algorithms performed well in the prediction of treatment response, 
with 75 to 83% accuracy. Amongst the variables with the highest importance for predictive 
accuracy were OCD onset, duration of OCD, self- and clinician-rated symptom severity, 
functional impairment, avoidance, and depressive symptoms.  
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4.6 ETHICAL CONSIDERATIONS 
All studies were approved by the Regional Ethical Review Board in Stockholm. The general 
risk of participating in this research was evaluated as low, as no serious side effects of CBT 
or ICBT are known. All patients and primary caregivers were informed verbally and in 
writing about the prerequisites for participation. Prior to inclusion of the first patients, we 
identified three important aspects to ensure optimal safety and integrity of the participating 
families: a) clear and age-appropriate informed consent for participation in the studies, b) data 
security of the ICBT platform and online self-ratings via encrypted servers and double 
authentication, c) and implementation of clinical routines concerning severe events or 
worsening of symptoms during ICBT or follow-up. Regarding the latter, our research unit 
was integrated into the regular child and adolescent mental health service in Stockholm when 
study II was conducted and could therefore refer to outpatient and inpatient, as well as 
specialized services, including a specialized OCD unit where patients could receive follow-up 
treatment if needed after participation in the ICBT study.  
As the tolerability of the novel ICBT intervention was not known prior to studies I and II, 
patients were a) informed that they could opt-out of participation anytime during the studies, 
and b) monitored by experienced clinicians as well as through weekly self-ratings to detect 
any signs of deterioration. Adverse events and patient satisfaction ratings were collected 
systematically at post-treatment.     
Finally, one could wonder if participation in an experimental treatment study involves a risk 
of not seeking other, more effective help, or, if ICBT would fail in being effective, a risk of 
giving patients the impression that CBT in general is ineffective. This potential risk was 
addressed by clear information to the patients that our ICBT intervention was a novel 
treatment format and currently in a developmental phase, and that regular face-to-face CBT 
would be the first alternative in case ICBT would not produce beneficial results. My personal 
clinical impression is that the participation in our trials did not keep patients from seeking 
help but, in contrast, was in many cases the first contact with psychological assessment and 
treatment, which later on facilitated identification of other comorbidity, such as autistic traits 
or anxiety disorders, and might therefore have been a “door opener” for some families for 
additional indicated psychiatric care.  
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5 DISCUSSION 
5.1 IS ICBT FEASIBLE FOR ADOLESCENT OCD?  
Study I aimed to inform us about the feasibility of BiP OCD in a sample of adolescents with 
OCD. As this was the first time that ICBT was tested for pediatric OCD, this was an 
important step and one that would impact the planning and design of studies II to IV. We 
found that all patients and parents in study I participated in the intervention. The adolescents 
completed on average eight of the twelve chapters while almost all parents completed all five 
parental chapters. BiP OCD received overall high satisfaction ratings from the patients. 
Clinically and technically our impression was that BiP OCD performed according to our 
expectations. Patients and parents communicated with the online therapists via exercises and 
messages through the platform, with occasional telephone calls if needed. The general 
structure and rationale of the treatment content appeared to be age-appropriate and 
comprehensible for the patients. Only very few patients expressed a preference for face-to-
face CBT when asked at post-treatment.  
The initial construction and design of BiP OCD was based on previous experiences with 
ICBT and treatment of OCD from within our group. Important conceptual cornerstones of the 
intervention were the three distinct phases of treatment (psychoeducation, ERP and relapse 
prevention) presented successively over 12 chapters within 12 weeks, the limitation of written 
text to a minimum and instead an emphasis on visual material, and the inclusion of parents as 
a supportive part of the intervention. These conceptual features were chosen out of practical 
considerations and previous experiences and were evaluated in an admittedly rather 
unstructured manner. According to qualitative patient interviews 
113
 and discussions within 
our group, our conclusion was that a) the general structure of the intervention was functional 
and intuitive for patients and clinicians, b) that the patients appreciated the flexible and 
accessible treatment format, and c) that adolescents manage to partly take responsibility for 
their ICBT treatment, but also need to be supported by their parents and an online therapist.  
Summarizing the accumulated knowledge from studies I and II, an improvement of BiP OCD 
would be to facilitate ERP further by clearer examples and routines as well as instructional 
video examples of how to conduct effective ERP exercises. Also, as adherence with the 
intervention is one of the key factors, we believe that the parental chapters could provide 
more detailed information about ERP, and how to support the adolescent in the best possible 
way to facilitate the treatment process. Reward systems, encouragement, and prompting are 
examples of tools that parents could make use of to a greater extent to support their 
adolescent.  
Between studies I and II we developed a mobile phone app which aimed to support ERP 
exercise training and registration. Guided by user data and clinical impression, we were 
surprised that the app appeared to add only limited functionality to the treatment, and was 
used frequently only by a minority of the patients. This led us to the conclusion that the next 
  26 
version of BiP OCD, which currently is in the making, will not include the mobile phone 
application.  
Limitations 
The feasibility aspects were evaluated in a qualitative manner with a pragmatic approach, 
rather than guided by an underlying theoretical framework. The disadvantage of a pragmatic 
approach is that some lessons learned tend to become implicit knowledge, available to those 
who have been directly involved in the process of the studies, but not apparent to others and 
difficult to pinpoint from an evidence-based research perspective. A more systematic way to 
approach the feasibility question would be to structure the data collection and analysis 
according to a theoretical framework. For example, Ritterband presents a theoretical model of 
various aspects of internet interventions, including technical, intervention, behavior change 
and symptom improvement aspects 
114
. Such models could help the field of ICBT to approach 
feasibility and design questions more methodical, with better operationalizations of key 
aspects and better possibilities to exchange important knowledge when constructing new or 
updating existing ICBT interventions.  
5.2 IS ICBT EFFECTIVE FOR ADOLESCENT OCD?  
Our initial pilot study and the subsequent RCT demonstrated that ICBT was effective for 
adolescents with OCD. ICBT yielded significant symptom reductions over the course of the 
12 weeks of treatment and, somewhat unexpected, additional improvements during follow-
up. The symptom severity levels three months after ICBT were on average in the subclinical 
range, about 10 points on the CY-BOCS in the pilot study and about 14 points in the RCT, 
which is well in the range of the effects usually seen in face-to-face CBT 
47
. Seventy percent 
of patients in the pilot study and one-third of patients in the RCT responded to the 
intervention. The difference in responder rates between the pilot and the RCT was rather 
surprising, and it appears that patients in the pilot study on average improved more than in the 
RCT. Apart from a true difference in effect, there are several methodological differences 
between the two studies that could explain the discrepancy: different study designs, unblinded 
vs. blinded assessors, a more strict definition of response and remission in the RCT, 
differences in the patient samples, and changes in the ICBT intervention.  
The delayed treatment effect from post-treatment to 3-months follow-up was not predicted by 
us, as this is not typical in face-to-face CBT for pediatric OCD, where the immediate 
symptom reductions normally occur at post-treatment and then are sustained during follow-
up 
84
. As we have observed additional improvements during follow-up in two different 
studies (study I and study II), as well as in a previous ICBT study on childhood anxiety 
115
, 
this could indicate a different pattern of improvement in ICBT. This, in turn, would mean that 
the true effect of ICBT is underestimated after 12 weeks of treatment. The primary endpoint 
in future trials should therefore be set at the 3- or 6-months follow-up time point.  
By and large, the ICBT treatment effects that were found in studies I and II are in line with 
the pooled effects of ICBT for children and adolescents presented in a recent meta-analysis 
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that found moderate between-group effect sizes of ICBT compared to waitlist, and large 
within-group effects from pre- to post-treatment 
88
. As stated by Vigerland et al., ICBT for 
children and adolescents is still in a developmental phase, and there are several unknown 
variables that need to be explored in order to potentially increase the efficacy of ICBT, such 
as the involvement of the parents, the presentation of ICBT content, and the amount of 
therapist contact 
88
. An ongoing Australian study of ICBT in pediatric OCD currently 
evaluates a completely unguided intervention, and the results from that trial will bring more 
knowledge about the advantages of self-guided ICBT and whether any reduction in efficacy 
can be detected when excluding therapist support 
116
.  
Limitations 
Several limitations apply to the presented efficacy results. First, the patient samples in studies 
I and II consisted predominantly of self-referrals and individuals volunteering for study 
participation. This might have introduced a selection bias in the data, as volunteers might be 
more motivated than clinician-referred patients, or could differ in other relevant 
characteristics from regular patients. In addition, the high proportion of highly educated 
parents indicates a possibly selected sample. This is likely a result of the recruitment process 
and advertisement for the studies in local newspapers. Yet, the samples had critical clinical 
characteristics such as moderate to severe OCD symptom presentation and clinical valid rates 
of comorbidity. About half of the patients had previously been in contact with the child and 
adolescent mental health services, indicating a subsample with clinical relevance. Still, 
effectiveness studies in clinical settings are needed to further validate the results.  
In addition, the design of studies I and II limit the generalizability of the efficacy results, with 
study I being an open trial without control condition and study II a single-blinded RCT with a 
waitlist control. The waitlist enabled us to control for the passage of time and thus rule out 
spontaneous remissions and the effect of repeated clinical assessments. Indeed, no patient on 
the waitlist achieved responder status, confirming that spontaneous remissions are unlikely to 
occur in OCD patients. An active comparator, however, would have enabled us to control for 
unspecific therapeutic factors, such as therapist contact and expectancy effects. When 
planning for the RCT, the choice of comparison condition was not straightforward. The 
comparison with a psychological placebo condition was not found intuitive at the time as 
ICBT is not a new treatment per se, but rather a new treatment format of CBT, and a logical 
comparator would therefore have been another treatment format of CBT. A comparison with 
face-to-face CBT would have been most informative, but was found premature at that early 
stage.  
5.3 IS ICBT A COST-EFFECTIVE INTERVENTION? 
Study III indicated that treating pediatric OCD with ICBT was associated with substantial 
cost-savings for society compared to leaving patients untreated on a waitlist. The cost-saving 
effect was observed already after 12 weeks of treatment and the main driver was the 
continued health care consumption in the waitlist group. This suggests that untreated OCD is 
associated with general health care utilization to a markedly larger extent than in treated 
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cases, and together with other service utilization, medication costs, school absence, and 
reduced productivity, the cost of not treating OCD could be higher than the cost of treating 
OCD with ICBT. From a health care provider perspective, the study indicated minimal 
additional costs for offering families the ICBT service, 20US$ per patient, or 2.3US$ per 
additional responder. The minimal additional health care cost was mainly due to two factors, 
the low cost of ICBT, and the continued utilization of health care in the waitlist group. 
Overall, as there are very few cost-effectiveness evaluations within ICBT for children and 
adolescents as well as within pediatric OCD, these results are an important first step towards 
a health economic evaluation of both fields.  
Limitations 
The cost-effectiveness results are limited to a 12-week perspective as patients on the waitlist 
directly were crossed over to ICBT, and further long-term cost comparisons could therefore 
not be made. As there seem to be additional clinical effects of ICBT during follow-up, we 
could hypothesize that these are accompanied by additional cost reductions. Critically, future 
studies should be designed with a longer controlled follow-up period to capture the cost-
effectiveness trajectory in the long run.  
Moreover, included in the cost estimates of ICBT were the maintenance costs of technical 
platform support and therapist costs. Not included, and more difficult to estimate, were the 
ICBT development costs. A service provider that would be interested in developing a new 
program and Internet platform would have to consider technical and content development 
costs as a one-off investment on top of the estimates presented in study III. 
As stated before, the results are also limited by a possibly selected study sample. In addition, 
the sample was not optimally powered for cost-effectiveness analyses, which is reflected in 
the confidence intervals of the cost estimates. The results should therefore be seen as 
preliminary. Furthermore, the cost data was mainly based on parent reports and could be 
flawed by recall bias or measurement error. Another way to collect more objective and 
reliable cost data would be to use medical records and registries, which would also be a more 
refined way to collect data over a longer time perspective.  
5.4 WHICH PEDIATRIC OCD PATIENTS DOES ICBT WORK FOR? 
Study IV aimed to identify relevant patient characteristics for the prediction of treatment 
response three months after ICBT. Despite classical regression analysis failing to identify 
significant predictors, machine learning demonstrated that treatment response of ICBT could 
be predicted with good accuracy, even with a moderately sized sample. The machine learning 
algorithms could predict treatment outcome at three months follow-up with 75 to 83% 
accuracy, which is comparable to the accuracy estimates found in previous machine learning 
prediction studies of remission in adult OCD 
64
 and methylphenidate response in children 
with ADHD 
117
. In our study, there was a slight advantage of the linear machine learning 
model over the non-linear models. However, as confidence intervals were overlapping and 
the sample size was modest, this difference should be interpreted cautiously.  
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The limitations of classical linear regression were also exemplified in the study, as predictor 
candidates were identified in the univariate analyses, but none reached significance in the 
multivariate analysis. This was probably due to collinearity of the two remaining variables in 
the model, age of OCD onset and duration of OCD. As this is a methodological limitation of 
our results, this problem would be expected to occur when multivariate linear regression is 
used in the kind of clinical data that is available in pediatric OCD studies. As the machine 
learning approach does not aim to identify single significant predictors in the same manner 
than linear regression, but rather patterns of predictors, issues like collinearity and non-
linearity are less problematic.  
The results of study IV provide therefore first exploratory evidence that machine learning 
could be a promising new statistical approach for the prediction of pediatric OCD treatment 
and ICBT outcome.  
Limitations 
The prediction results from study IV are limited by a possible sample selection bias, as 
described earlier for study II, and should be replicated in a bigger sample of patients from a 
clinical context. This is important, as we would want to make predictions of ICBT treatment 
outcome within regular care and on patients that present at the regional mental health care 
services.  
Amongst the most important variables in the algorithms that predicted response to ICBT we 
identified OCD onset, duration of OCD, self- and clinician-rated symptom severity, 
functional impairment, avoidance, and depressive symptoms. This could indicate that patients 
that were detected and treated earlier and had a less severe clinical presentation were the ones 
that benefited the most from ICBT. At the same time, machine learning algorithms cannot be 
interpreted in the same intuitive way as linear regression results, and especially results from 
non-linear algorithms can be rather intricate 
118
. The machine learning results should be 
understood as an interactive pattern of all included variables, and while some variables were 
identified as more important than others, their individual contribution should not be taken out 
of the context of all the available data. One weakness of machine learning is therefore the loss 
of interpretability, in the sense that it might not allow us to state that patients that had high 
scores on a particular variable did have worse outcomes. Simply put, machine learning might 
be most useful in situations where the aim is to predict, but not to make inferences about 
individual predictors.  
All prediction analyses in this thesis were conducted on demographic variables and, 
predominantly, total scores from the clinical rating scales. Machine learning, in contrast to 
classical regression, is able to handle information on single item level. The reason we chose 
to use total scores instead of single items is that we aimed to compare machine learning with 
a classical linear regression and base the analyses on the same information. Future studies 
should however make use of machine learning algorithms’ full potential and provide single 
item information alongside with total scores.  
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5.5 FUTURE DIRECTIONS 
Further improvement of ICBT  
As ICBT for children and adolescents still is a field in its early stages, there are many open 
questions about how to design and present an ICBT intervention in the best possible way to 
yield optimal clinical results. The studies presented in this thesis are designed to answer the 
question “Does it work?”, but leave the actual intervention as a black box with unknown 
mechanics on the inside, and thus tell us little about “Why does it work?”. Various central 
aspects of ICBT, such as length of intervention, graphical presentation, text and image 
content, degree of parental involvement and therapist support, are currently poorly 
understood. As mentioned before, a theoretical framework could guide researchers to 
systematically accumulate valuable knowledge about the most important ingredients of a 
successful ICBT intervention for children and adolescents. Some intervention characteristics 
could be experimentally randomized or studied by means of mediation analysis, e.g. length 
and intensity of the intervention or degree of parental support, whereas other aspects might 
require qualitative patient interviews and focus groups, e.g. readability of written material and 
appearance of visual material.  
Continued evaluation of the clinical efficacy of ICBT 
The next logical step regarding clinical efficacy of ICBT for pediatric OCD would be to 
compare BiP OCD with an active control, such as treatment as usual, or standard face-to-face 
CBT. The majority of patients in studies I and II that previously had been in contact with the 
child and adolescent mental health services had received general counseling. It might 
therefore be the case that many patients currently are offered unspecific, supportive 
psychological treatment, perhaps due to the absence of CBT-trained clinicians. Therefore, an 
unspecific supportive intervention would be a credible comparison condition to ICBT.  
Naturally, a head-to-head comparison of ICBT with gold standard face-to-face CBT would be 
very interesting and important. The responder rates and average symptom reductions in study 
II are suggesting that ICBT might be less effective than face-to-face CBT, at least at post-
treatment. A direct non-inferiority comparison would inform us if that indeed is true, and, in 
that case, how much of a discrepancy there is between the effect of CBT and ICBT. It has 
been proposed earlier that ICBT could be the first step in a stepped-care care model of OCD 
treatment, with face-to-face CBT and multimodal treatment reserved for more complex and 
severe cases 
119
. Even if ICBT would be less effective than face-to-face CBT, it is intuitive 
that such a stepped-care model could save limited resources and might be attractive for 
different kinds of patients, and their different needs and preferences.  
Further evaluation of the cost-effectiveness of ICBT  
Related to the previous section and the further evaluation of the clinical efficacy of ICBT, the 
next step for the evaluation of the cost-effectiveness of ICBT should involve comparisons 
with other active treatments. Regarding the comparison with treatment as usual and 
unspecific supportive therapy, such treatments are expected to yield suboptimal effects but 
still involve clinician time and booked appointments, which in turn is associated with costs 
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for health care providers and society. It would therefore be interesting to compare the 
involved costs in relation to the effects that are yielded by unspecific interventions, such as 
general counseling or supportive therapy, compared to ICBT.  
ICBT should also be compared directly with gold standard face-to-face CBT, and even if 
face-to-face treatment might be expected to be more effective than ICBT, ICBT could still be 
cost-effective, due to reduced clinician times (about 17 to 20 minutes per patient and week, 
compared to about 45 to 60 minutes in face-to-face CBT).  
Critically, as OCD is associated with profound impairments in family, educational, and 
occupational everyday life 
16
, a long-term follow-up of ICBT-treated patients would be very 
interesting regarding societal functioning and productivity indicators. Such an evaluation 
could preferably be done within the Swedish registries, which contain rich longitudinal 
information on psychiatric and somatic diagnoses, health service utilization, sick leave, and 
employment status. A more refined long-term data collection of treatment effects and societal 
costs would therefore provide us with important insights on ICBT and whether it has 
potential to prevent functional and productivity impairments that often are associated with 
OCD.  
Optimized prediction of ICBT outcome 
As study IV suggested feasibility and accuracy of machine learning in the prediction of ICBT 
treatment response, a next important step would be to replicate these preliminary results in a 
larger clinical sample. Preferably, this would be done with separated recruitments of patients 
to first train the algorithms in one sample and then test the algorithms in a new sample, which 
would greatly expand the validity of results and would establish generalizability of the 
algorithm.  
Another interesting study would be to replicate Kim et al.’s methylphenidate study 117 in an 
OCD sample and include genetic, imaging, environmental, neuropsychological, and 
psychometric data in the prediction of OCD treatment response. This combination of 
different sources of predictors has in fact been a successful strategy within cancer research, 
where many studies combine a multivariate set of genomic, clinical, histological, imaging, 
demographic, epidemiological, and protein data 
63
. A comparable approach has been applied 
from within the field of therapygenetics, which is a development from within the genetics 
field and aims to predict psychotherapy outcome based on genes. E.g., in one study of CBT 
for child anxiety, a combination of genetic, demographic and clinical variables could 
successfully predict CBT outcome (area under the curve, AUC =.62–.69), using linear 
regression with cross-validation 
120
.  
Such multidimensional prediction approaches appear promising, as they more closely reflect 
how we theoretically understand the causes and mechanisms of psychopathology, namely as 
a dynamic interplay of genetic, environmental, neurofunctional, and psychological 
mechanisms 
24
. A problem in the previous OCD literature has been a large proportion of 
underpowered studies with not large enough samples to detect multiple predictors 
60
. As 
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ICBT studies traditionally have been successful in recruiting large patient samples relatively 
quick, with inclusion processes usually completed within one year, combining large-scale 
ICBT trials with a multidimensional data collection from various sources, using machine 
learning as a tool to analyze the complex data, would be an interesting new development 
within the prediction field.  
Dissemination of ICBT and evaluation of increased availability 
The overarching aim of the line of research presented in this thesis is to increase the 
availability of effective psychological treatment for pediatric OCD. If ICBT after rigorous 
scientific evaluation proves to be an effective, cost- and resource-efficient intervention with 
the potential to bridge existing treatment barriers, the next necessary step would be 
implementation on a broader scale. Implementation studies could inform health care 
providers and decision makers of important issues to consider before integration of ICBT 
within a local service or the national health care system. An example of a regional 
implementation trial is a currently ongoing evaluation of ICBT for pediatric anxiety and OCD 
through a collaboration of our research group with the child and adolescent mental health 
care service in Östersund, a Swedish rural region where one clinic covers a large, sparsely 
populated area.  
Apart from practical issues, there are specific questions that are associated with the 
implementation of ICBT that should be addressed within implementation trials, such as 
technical and clinical safety, reimbursement, maintenance and updates of the technology, the 
ongoing evaluation of ICBT effectiveness within clinical practice and legal questions about 
ownership and responsibilities.  
As increased availability of psychological treatment is the goal, it would be important if the 
availability of treatment could be measured locally and nationally. Swedish registries cover 
various aspects of health care on a national level, but not yet the availability of psychological 
treatments. There are current initiatives to implement national quality registries of both 
psychological treatments within child and adolescent mental health care, as well as ICBT 
registries. An installation of those registries could give us highly relevant data about the 
geographic distribution of services and could inform us about under-supplied regions and 
guide the allocation of resources more equitable as we believe it currently to be the case.  
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6 CONCLUSIONS 
The aim of this thesis was to develop and evaluate ICBT for adolescent OCD. Four studies 
were conducted to evaluate the feasibility, efficacy, cost-effectiveness, and prediction of 
treatment outcomes using ICBT. In summary, the research project demonstrated that: 
 ICBT is a feasible intervention for adolescents aged 12 to 17 years with OCD 
 ICBT is a clinically effective intervention for adolescent OCD, leading to significant 
symptom reductions in primary measures of OCD symptom severity and secondary 
measures of OCD symptoms, impairment, and comorbid symptoms 
 ICBT is a highly satisfactory treatment from the patients’ point of view  
 ICBT is a safe intervention 
 ICBT has the potential to save clinician time, requiring on average below 20 min per 
patient and week  
 ICBT is less costly for society than leaving patients untreated on a waitlist 
 ICBT treatment outcome could accurately be predicted by machine learning 
algorithms 
This initial evaluation of ICBT for pediatric OCD is encouraging, but warrants replication in 
larger, clinical samples and should be extended to active control trials or non-inferiority trials 
that include not only an efficacy but also a cost-effectiveness component.  
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